Neuro‐ophthalmological findings in sarcoidosis

Wiley - Tập 82 Số 6 - Trang 723-729 - 2004
Kjell Heuser1, Emı́lia Kerty1
1Department of Neurology, Rikshospitalet, University of Oslo, Oslo, Norway

Tóm tắt

Abstract.Purpose:  This review emphasizes the importance of neuro‐ophthalmological signs and symptoms in sarcoidosis. The presence of ophthalmological and neuro‐ophthalmological findings may lead to diagnosis of the disease and the initiation of adequate treatment. Material and Methods:  Patients who had been diagnosed with neurosarcoidosis during the period 1990 − 2001 were identified from the departmental diagnostic index. The history, clinical, laboratory and imaging data of patients were analysed. Results:  Fifteen patients were identified, four men and 11 women, with a mean age of 44.1 years (range 26–65 years). In six of the 15 (40%), neurological deficits were the initial symptoms. Nine (60%) had known sarcoidosis at the time of presentation. Ten patients (66%) had ophthalmological/neuro‐ophthalmological symptoms and signs. Conclusion:  Neuro‐ophthalmological symptoms may develop early in neurosarcoidosis. If neuro‐ophthalmological symptoms arise in patients with established biopsy‐proven sarcoidosis, the diagnosis is usually easy to make. However, a number of patients with neurosarcoidosis may present with neuro‐ophthalmic symptoms before systemic involvement becomes obvious. In this situation the diagnosis is challenging, and the major goal is to establish the presence of systemic sarcoidosis.

Từ khóa


Tài liệu tham khảo

Allen RKA, 2003, A prospective study of 32 patients with neurosarcoidosis, Sarcoidosis Vasc Diffuse Lung Dis, 20, 118

10.1016/0002-9394(87)90406-5

10.1016/S0002-9394(02)01959-1

10.1016/S0140-6736(07)60417-6

10.1016/0030-4220(82)90343-7

Dale JC, 1999, Determination of angiotensin‐converting enzyme levels in cerebrospinal fluid is not a useful test for the diagnosis of neurosarcoidosis, Mayo Clin Proc, 75, 318

10.1136/jnnp.51.12.1473

10.1212/WNL.32.6.597

10.1177/0333102499019S2508

10.1136/bjo.57.10.792

10.1016/0002-9394(86)90001-2

10.1016/S0161-6420(93)31659-3

James DG, 1997, Differential diagnosis of facial nerve palsy, Sarcoidosis Vasc Diffuse Lung Dis, 14, 115

10.1097/00055735-200212000-00009

10.1097/00041327-200309000-00001

10.1001/archopht.1973.01000040488008

Kidd D, 2003, The neurological complications of systemic sarcoidosis, Sarcoidosis Vasc Diffuse Lung Dis, 20, 85

10.1016/0039-6257(82)90190-4

10.1136/jnnp.71.5.577

10.1007/BF00256821

10.3109/01658108409019491

10.1001/archinte.157.16.1864

10.1016/S0272-5231(05)70417-2

10.1017/S0317167100044577

10.3171/jns.2000.93.5.0897

10.1212/WNL.35.8.1220

10.1136/bjo.84.1.110

10.1001/archneur.1985.04060080095022

10.1212/WNL.31.12.1545

Tahmoush AJ, 2002, CSF‐ACE activity in probable CNS neurosarcoidosis, Sarcoidosis Vasc Diffuse Lung Dis, 19, 191

10.1093/qjmed/92.2.103